| 561327-14-8

• 分子结构分类: 有机化合物 - 有机氧化合物
• CAS: 561327-14-8
• 化学式: C₃₃H₅₈N₂O₁₂
• 分子量: 674.83
• InChiKey: QMNAYJKXICCKLP-NEVKUDHYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.78
• 重原子数：
  47.0
• 可旋转键数：
  6.0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  193.88
• 氢给体数：
  4.0
• 氢受体数：
  14.0

反应信息

• 作为反应物：
  描述：

  在 吡啶 、 盐酸 、 甲醇 、 三甲基乙酰氯 、 三乙胺 、 sodium nitrite 作用下， 以 甲醇 、 二氯甲烷 为溶剂， 反应 10.0h， 生成 5-O-desosaminyl-3-O-(3-pyridyl)acetylerythronolide A 11,12-cyclic carbonate
  参考文献：
  名称：

  Synthesis and Antibacterial Activity of a Novel Series of Acylides:  3-O-(3-Pyridyl)acetylerythromycin A Derivatives

  摘要：

  A novel series of acylides, 3-O-(aryl)acetylerythromycin A derivatives, were synthesized and evaluated. These compounds have significant potent antibacterial activity against not only Gram-positive pathogens, including inducibly macrolide-lincosamide-streptogramin B (MLSB)-resistant and efflux-resistant strains, but also Gram-negative pathogens, such as H. influenzae. 6,9:11,12-Dicarbonate acylide 47 (FMA0122) was twice as active against H. influenzae than azithromycin, whereas it showed only moderate in vivo efficacy in mouse protection tests. However, the 11,12-carbamate acylide 19 (TEA0929), which showed potent antibacterial activity against almost all of the main causative pathogens of community-acquired pneumonia tested, exhibited excellent in vivo efficacy comparable to those of second-generation macrolides.

  DOI：

  10.1021/jm020568d
• 作为产物：
  描述：

  乙酸酐 、 3-O-去克拉定糖红霉素肟 在 sodium carbonate 作用下， 以 二氯甲烷 为溶剂， 反应 3.0h， 以97%的产率得到
  参考文献：
  名称：

  Synthesis and Antibacterial Activity of a Novel Series of Acylides:  3-O-(3-Pyridyl)acetylerythromycin A Derivatives

  摘要：

  A novel series of acylides, 3-O-(aryl)acetylerythromycin A derivatives, were synthesized and evaluated. These compounds have significant potent antibacterial activity against not only Gram-positive pathogens, including inducibly macrolide-lincosamide-streptogramin B (MLSB)-resistant and efflux-resistant strains, but also Gram-negative pathogens, such as H. influenzae. 6,9:11,12-Dicarbonate acylide 47 (FMA0122) was twice as active against H. influenzae than azithromycin, whereas it showed only moderate in vivo efficacy in mouse protection tests. However, the 11,12-carbamate acylide 19 (TEA0929), which showed potent antibacterial activity against almost all of the main causative pathogens of community-acquired pneumonia tested, exhibited excellent in vivo efficacy comparable to those of second-generation macrolides.

  DOI：

  10.1021/jm020568d

文献信息

• WO2006/65721
  申请人：——

  公开号：——

  公开（公告）日：——
• WO2007/115278
  申请人：——

  公开号：——

  公开（公告）日：——
• WO2006/65743
  申请人：——

  公开号：——

  公开（公告）日：——